Publication:
Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer

Simple item page
dc.contributor.authorsBrausi, M. A.; Oddens, J. R.; Sylvester, R. J.; Bono, A., V; Van de Beek, C.; Van Andel, G.; Gontero, P.; Hoeltl, W.; Turkeri, L.; Collette, S.; Oosterlinck, W.
dc.date.accessioned2022-03-10T17:51:14Z
dc.date.accessioned2026-01-10T18:52:13Z
dc.date.available2022-03-10T17:51:14Z
dc.date.issued2012
dc.identifier.doidoiWOS:000303001302097
dc.identifier.issn1569-9056
dc.identifier.urihttps://hdl.handle.net/11424/221464
dc.identifier.wosWOS:000303001302097
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofEUROPEAN UROLOGY SUPPLEMENTS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleBacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageU193
oaire.citation.issue1
oaire.citation.startPageE1050
oaire.citation.titleEUROPEAN UROLOGY SUPPLEMENTS
oaire.citation.volume11

Files

Collections

Araştırma Çıktıları